3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
143
Neoplasm Metastasis
16
Ovarian Neoplasms
6
Advanced Breast Cancer
6
Prostatic Neoplasms
5
Breast Cancer Metastatic
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Lobular
3
Lung Neoplasms
2
HER2-positive Breast Cancer
2
Exanthema
2
Estrogen Receptor-positive Breast Cancer
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms, Male
2
Triple Negative Breast Neoplasms
1
The Neoadjuvant Therapy
1
Stomach Neoplasms
1
Solid Tumor
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Endometrial Stromal
1
Sarcoma
1
Salivary Gland Neoplasms
1
Patient Acceptance of Health Care
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Malignant Neoplasms of Female Genital Organs
1
Interventions
Blood Specimen Collection
25
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Liquid Biopsy
4
cabazitaxel
3
Surgical Procedures, Operative
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Trastuzumab
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplastic Cells, Circulating
×
Fulvestrant
×
Clear all
NCT02958852
2025-09-10
ABC-SE
Lund University Hospital
Phase 2
Completed
126 enrolled